Why the study?
REBOA is useful for bleeding control in placenta accreta spectrum, but the incidence of associated complications is variable.
Does REBOA use in placenta accreta spectrum cause arterial thrombosis?
Does REBOA use in placenta accreta spectrum cause arterial thrombosis?
REBOA use in placenta accreta spectrum can be complicated by arterial thrombosis, highlighting the need for ultrasound guidance and heparin use during the procedure.
Thrombosis risk warrants procedural vigilance in PAS; leaves open optimal mitigation strategies for future study.
BACKGROUND: The use of resuscitative endovascular balloon of the aorta (REBOA) is a useful strategy for bleeding control in placenta accreta spectrum (PAS) management. The incidence of complications associated with this procedure is variable. We report three cases of arterial thrombosis associated with REBOA, and we also analyze the factors that facilitated its occurrence. CASE REPORT: Three women with PAS, presented common femoral and external iliac arterial thrombosis after REBOA use. Among the contributing factors probably associated with thrombosis, we identified the absence of ultrasound guidance for vascular access and the not using of heparin during aortic occlusion. CONCLUSIONS: REBOA use is not exempt from complications and must be performed by experienced groups applying strategies to reduce the risks of complications.
No takes yet. Share an insight, caveat, or question.
Nieto‐Calvache et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: